NEW HAVEN — A minimally invasive surgical tool has attracted a $1 million push toward reality. Yale technology-based NovaTract Surgical was awarded the funding from Connecticut Innovations Inc. after having received nearly half a million dollars in two previous funding rounds since 2010.
The NovaTract surgical device is an internal organ retractor designed to assist in cutting down the number of incisions, particularly in abdominal surgeries, such click here for gall bladder removals and appendectomies.
The deviceÂ’s technology was licensed from Yale surgeon Kurt here MD. The prototype design and manufacturing is complete, and animal testing will be completed this December. The first device is expected to hit the market by valium online.
|< Prev||Next >|